| Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme C Taillé, P Chanez, G Devouassoux, A Didier, C Pison, G Garcia, ... European Respiratory Journal 55 (6), 2020 | 68 | 2020 |
| Future treatment for asthma J Charriot, I Vachier, L Halimi, AS Gamez, C Boissin, M Salama, ... European Respiratory Review 25 (139), 77-92, 2016 | 44 | 2016 |
| Epithelial ciliated beating cells essential for ex vivo ALI culture growth D Gras, A Petit, J Charriot, L Knabe, K Alagha, AS Gamez, C Garulli, ... BMC pulmonary medicine 17, 1-7, 2017 | 26 | 2017 |
| Goblet cell hyperplasia as a feature of neutrophilic asthma K Alagha, A Bourdin, C Vernisse, C Garulli, C Tummino, J Charriot, ... Clinical & Experimental Allergy 49 (6), 781-788, 2019 | 20 | 2019 |
| CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis L Knabe, A Petit, C Vernisse, J Charriot, M Pugnière, C Henriquet, ... European Respiratory Journal 54 (1), 2019 | 16 | 2019 |
| Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases M Volpato, J Vialaret, C Hirtz, A Petit, C Suehs, J Patarin, E Matzner-Lober, ... Biochemical and Biophysical Research Communications 622, 64-71, 2022 | 9 | 2022 |
| Methods of sputum and mucus assessment for muco-obstructive lung diseases in 2022: time to “unplug” from our daily routine! J Charriot, M Volpato, A Petit, I Vachier, A Bourdin Cells 11 (5), 812, 2022 | 9 | 2022 |
| Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience R Chiron, W Hoefsloot, J Van Ingen, H Marchandin, L Kremer, ... Open Forum Infectious Diseases 9 (10), ofac465, 2022 | 8 | 2022 |
| Differentiating between active and latent tuberculosis with chest computed tomography S Bommart, J Charriot, N Nagot, H Vernhet-Kovacsik, MP Revel, ... Diagnostic and Interventional Imaging 102 (10), 605-610, 2021 | 8 | 2021 |
| Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship A Bourdin, C Suehs, J Charriot European Respiratory Journal 55 (1), 2020 | 7 | 2020 |
| Tracheobronchopathia osteochondroplastica: clinical, bronchoscopic, and comorbid features in a case series A Dumazet, C Launois, F Lebargy, R Kessler, H Vallerand, P Schmitt, ... BMC Pulmonary Medicine 22 (1), 423, 2022 | 6 | 2022 |
| “Real-life” management of patients with severe asthma in the biologics era: Can we do better? J Charriot, M Maravic, M Huguet, I Vachier, C Suehs, A Bourdin World Allergy Organization Journal 14 (4), 100528, 2021 | 6 | 2021 |
| The six million dollar man M Volpato, S Nowak, JL Bourrain, P Demoly, E Ahmed, A Bourdin, ... ERJ Open Research 7 (1), 2021 | 6 | 2021 |
| PD-L1 inhibitor-induced worsening of eosinophilic obstructive lung disease successfully rescued with anti-interleukin 5 receptor (IL-5R) therapy F Wassmer, C Suehs, C Boissin, A Bourdin, J Charriot The Journal of Allergy and Clinical Immunology: In Practice 9 (1), 567-569, 2021 | 6 | 2021 |
| Targeted therapies in severe asthma: the discovery of new molecules J Charriot, AS Gamez, M Humbert, P Chanez, A Bourdin Revue des maladies respiratoires 30 (8), 613-626, 2013 | 6 | 2013 |
| Association between T2-related comorbidities and effectiveness of biologics in severe asthma ME Wechsler, G Scelo, DES Larenas-Linnemann, CA Torres-Duque, ... American journal of respiratory and critical care medicine 209 (3), 262-272, 2024 | 5* | 2024 |
| Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry G Scelo, CA Torres-Duque, J Maspero, TN Tran, R Murray, N Martin, ... Annals of Allergy, Asthma & Immunology 132 (1), 42-53, 2024 | 5 | 2024 |
| Will the asthma revolution fostered by biologics also benefit adult ICU patients? A Bourdin, J Charriot, C Boissin, E Ahmed, C Suehs, A De Sevin, ... Allergy 76 (8), 2395-2406, 2021 | 5 | 2021 |
| Asthma rescue treatments, time to reboot J Charriot, M Gaga, C Suehs, A Bourdin European Respiratory Journal 55 (4), 2020 | 4 | 2020 |
| What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis? V Favier, J Charriot, L Crampette, A Bourdin, E Ahmed Expert Review of Clinical Immunology 19 (8), 821-825, 2023 | 3 | 2023 |
